The AI In Bioinformatics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The AI In Bioinformatics Market:
https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report
According to The Business Research Company’s AI In Bioinformatics Global Market Report 2024, The AI in bioinformatics market size is expected to see exponential growth in the next few years. It will grow to $18.35 billion in 2028 at a compound annual growth rate (CAGR) of 43.8%. The growth in the forecast period can be attributed to expansion of single-cell technologies, growing emphasis on multi-omics integration, rising focus on functional genomics, acceleration of drug repurposing, increasing adoption of ai in pathology. Major trends in the forecast period include ethical AI and responsible data use, AI-driven virtual laboratories, integration of quantum computing, AI-powered clinical trials, and blockchain for secure data sharing.
The increasing number of clinical trials is expected to propel the growth of AI in the bioinformatics market going forward. Clinical trials refer to a systematic and carefully designed process of conducting medical research involving human participants to evaluate the safety, efficacy, and effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. AI in bioinformatics is used in clinical trials to analyze patient data from electronic health records and other sources to identify potential candidates for clinical trials who meet specific criteria, improving recruitment efficiency and targeting. For instance, in May 2023, according to Xtalks, a Canada-based life science and medical device platform, on ClinicalTrials.gov, there were 452,604 clinical trials registered worldwide as of May 2023, and 64,838 of the total number of registered studies are actively seeking participants. Further, the number of registered trials has significantly increased from the over 365,000 that were reported at the beginning of 2021. Therefore, the increasing number of clinical trials is driving the growth of AI in the bioinformatics market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp
The ai in bioinformatics market covered in this report is segmented –
1) By Type: Machine Learning, Deep Learning, Other Types
2) By Offering : Services, Software
3) By Application: Genomics, Chemoinformatics and Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, Other Applications
Major companies operating in the AI in bioinformatics market are innovating technological advancements on the Bionl.AI platform to increase their profitability in the market. Bionl.AI offers an all-in-one workspace for exploration, analysis, and visualization, cutting down the time required to complete complicated tasks from days to minutes. For instance, in October 2023, Bionl Inc., a US-based biomedical and bioinformatics research platform company, launched Bionl.AI, a pioneering platform that aims to revolutionize biomedical and bioinformatics research by providing a no-code solution for researchers, students, and professionals to investigate biomedicine using natural language queries. The platform leverages state-of-the-art GenAI models to enable instant insights and make complex analysis accessible and engaging.
The ai in bioinformatics market report table of contents includes:
1. Executive Summary
2.AI In Bioinformatics Market Characteristics
3.AI In Bioinformatics Market Trends And Strategies
4.AI In Bioinformatics Market analysis
5.AI In Bioinformatics Market Size And Growth
6.AI In Bioinformatics Segmentation
7.AI In Bioinformatics Regional And Country Analysis
.
.
.
27.AI In Bioinformatics Competitive Landscape And Company Profiles
28.AI In Bioinformatics Key Mergers And Acquisitions
29.AI In Bioinformatics Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Thermo Fisher Scientific Inc.
- Eurofins Scientific SE
- Dassault Systèmes SE
- Illumina Inc.
- NeoGenomics Laboratories Inc.
- QIAGEN N.V.
- SomaLogic Operating Co. Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
